Functional drug screening assay reveals potential glioma therapeutics.
about
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizerA real time Metridia luciferase based non-invasive reporter assay of mammalian cell viability and cytotoxicity via the β-actin promoter and enhancer.Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability.Multimodal in vivo imaging and blood monitoring of intrinsic and extrinsic apoptosis.Secreted blood reporters: insights and applications.Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway.Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapyNovel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactionsTargeting cancer cells with the natural compound obtusaquinone.Triple bioluminescence imaging for in vivo monitoring of cellular processes.Bioluminescence imaging: progress and applicationsIdentification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma MultiformeSecreted Reporters for Monitoring Multiple Promoter Function.Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype.High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.Optimized application of the secreted Nano-luciferase reporter system using an affinity purification strategy.
P2860
Q28822232-E1D3DD43-B11A-4F4D-89C6-F23ECEEC8E0CQ34270806-1A03B4DE-5FDE-412B-8C4F-0F3FF6D5E069Q34593139-83FA2EAB-A001-4693-82B2-264403EF35B2Q35086733-DF659FC6-E794-4F51-893D-C7A6C28F7179Q35294368-49289254-FA2E-4CCE-8BF5-7DE4F55511F0Q35419466-01F7AB67-2C47-4282-84A4-24CFA6853A19Q35679830-5E43D7AA-E229-4853-8F16-FCA9020E586BQ35749822-2A2DCB6B-5A60-4146-8F23-27BC63ED2524Q36953575-6738458A-F7F1-4395-9CF7-33F119F140CEQ36968192-2E0038D8-AF50-483C-BC5D-D5255E26548FQ37905334-0A01C87C-5D78-4698-8F80-90B1E8D16EECQ42577813-7DF8A0A4-E5D0-4D4D-9629-BDD44F2C1346Q47961707-5401ADD3-3702-402F-8FB3-17988782AFA1Q47988508-B888EC55-7D2C-4F26-BE71-4A24FF1FBE66Q52677063-9E4C4EF6-ECF9-4038-B48A-E3AC0D276194Q54965253-5D81C5DE-666C-491C-A71C-26999537944C
P2860
Functional drug screening assay reveals potential glioma therapeutics.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Functional drug screening assay reveals potential glioma therapeutics.
@ast
Functional drug screening assay reveals potential glioma therapeutics.
@en
type
label
Functional drug screening assay reveals potential glioma therapeutics.
@ast
Functional drug screening assay reveals potential glioma therapeutics.
@en
prefLabel
Functional drug screening assay reveals potential glioma therapeutics.
@ast
Functional drug screening assay reveals potential glioma therapeutics.
@en
P2093
P2860
P356
P1476
Functional drug screening assay reveals potential glioma therapeutics.
@en
P2093
Bakhos A Tannous
Christian E Badr
Thomas Wurdinger
P2860
P304
P356
10.1089/ADT.2010.0324
P577
2010-12-27T00:00:00Z